REVOLAX™

REVOLAX™ Technology — Highly Purified Biodegradable HA

REVOLAX™ is formulated with cross-linked, biodegradable hyaluronic acid derived from non-animal sources. The range uses a monophasic gel architecture — meaning the HA is processed into a uniform, consistent matrix rather than combining particles of different sizes. This approach is intended to support smooth extrusion force, even tissue integration, and predictable correction across injection depths. [1][5]

What sets REVOLAX™ apart in the Korean HA filler category is its emphasis on high purity. The manufacturing process is designed to minimize residual BDDE cross-linker levels — a relevant consideration for practitioners comparing HA fillers on safety and biocompatibility criteria. Hyaluronic acid molecules naturally bind water and support tissue hydration; cross-linking stabilizes this structure, extending the gel’s functional life in tissue, with the degree of cross-linking influencing filler stiffness, cohesivity, and degradation rate. [1]

Duration of effect varies by product, treatment area, patient metabolism, and injection technique. Based on manufacturer positioning, REVOLAX™ Fine is typically described as lasting approximately 6 to 9 months. REVOLAX™ Deep and REVOLAX™ Sub-Q are used for deeper correction and may deliver results lasting approximately 12 to 18 months in selected patients, consistent with clinical observations for HA fillers used in volume restoration at equivalent depths, though individual results may vary. [2][5]

About REVOLAX™ — Highly Purified Korean HA Filler

REVOLAX™ is a Korean HA dermal filler line used by licensed aesthetic practitioners for wrinkle correction, lip augmentation, facial contouring, and soft-tissue volume restoration. It is organized into three viscosity grades — Fine, Deep, and Sub-Q — each calibrated for a distinct injection depth and clinical purpose, making it a system that can serve a wide range of treatment indications from a single brand. [1][5]

The range’s monophasic cross-linked HA formulation is designed to support consistent texture and integration across treatment areas. REVOLAX™ sits within a growing category of high-purity Korean options that practitioners can evaluate when they buy Korean dermal fillers through Doctor Medica — its three-grade viscosity structure making it a practical anchor for clinics that want superficial-to-deep correction coverage from a single brand.

About the Manufacturer

REVOLAX™ is manufactured by Across Co., Ltd., a South Korean company specializing in hyaluronic acid filler production. Across describes REVOLAX™ as a highly purified, biodegradable HA filler range designed for wrinkle improvement and soft-tissue restoration, with product differentiation based on viscosity, injection depth, and treatment indication. [5]

The company produces REVOLAX™ Fine, Deep, and Sub-Q using in-house HA purification and cross-linking technology, with CE-marked production aligned to Korean MFDS regulatory standards. Because product registration, packaging, distribution rights, and available presentations vary by market, practitioners should verify the manufacturer documentation, product IFU, CE documentation, and local regulatory status applicable to their jurisdiction before treatment or procurement. [4][5]

REVOLAX™ Product Range — Fine, Deep, and Sub-Q

The REVOLAX™ filler range is organized around three viscosity grades, each designed for a defined level of correction and injection depth. REVOLAX™ Fine is the lowest-viscosity option, used for superficial lines, glabellar lines, neck wrinkles, and delicate facial corrections where soft tissue integration is the priority. REVOLAX™ Deep is a medium-viscosity filler selected for nasolabial folds, lip augmentation, marionette lines, and cheek contouring. REVOLAX™ Sub-Q is the densest formulation, intended for deeper volumization, chin augmentation, jawline definition, and structural facial contouring at aesthetic implant depth. [5]

Each category is available with or without lidocaine depending on the market and product presentation. Lidocaine variants allow practitioners to buy REVOLAX™ dermal filler with integrated analgesia, reducing patient discomfort during treatment without altering the core HA formulation’s correction profile. Practitioners selecting between variants should factor in viscosity, HA concentration, injection depth, treatment area, patient anatomy, and lidocaine sensitivity. Clinics expanding their injectable inventory can browse the full selection of options available to buy HA dermal fillers through Doctor Medica alongside the REVOLAX™ range.

Most Popular REVOLAX™ Products

REVOLAX™ Fine

A low-viscosity HA filler for superficial dermal placement. Commonly selected for fine facial lines, forehead lines, crow’s feet, glabellar lines, and neck wrinkles where soft integration and minimal tissue disruption are preferred. [5]

REVOLAX™ Fine with Lidocaine

A comfort-enhanced version of REVOLAX™ Fine incorporating lidocaine to reduce discomfort during administration. Useful for sensitive treatment areas or patients who benefit from reduced injection pain without changing the clinical correction profile. [5]

REVOLAX™ Deep

A medium-viscosity REVOLAX™ filler used for deeper facial wrinkles, nasolabial folds, lip augmentation, cheek support, and marionette lines. Frequently discussed as a REVOLAX™ deep filler and REVOLAX™ lip filler option, it sits at the core of most REVOLAX™ treatment protocols for mid-face and lip indications. [5]

REVOLAX™ Deep with Lidocaine

A lidocaine-containing version of REVOLAX™ Deep for nasolabial folds, lips, cheeks, and facial augmentation where both controlled placement and patient comfort are clinical priorities. [5]

REVOLAX™ Sub-Q

A high-viscosity filler designed for deeper subcutaneous placement and structural correction. Selected for chin filler protocols, jawline definition, cheek volumization, and deep facial sculpting where projection and shape support are required. [5]

REVOLAX™ Sub-Q with Lidocaine

A comfort-enhanced version of REVOLAX™ Sub-Q for deeper contouring and volumization procedures. The lidocaine inclusion supports patient tolerance during longer or more involved structural correction sessions. [5]

Treatment Areas — Fine Lines to Deep Volumisation

REVOLAX™ treatment areas are determined by product viscosity and injection depth. Matching the formulation to the patient’s anatomy, skin thickness, degree of volume loss, and aesthetic goal is essential for clinical outcomes. [1][5]

• REVOLAX™ Fine: Superficial facial lines, forehead lines, crow’s feet, glabellar lines and neck wrinkles, periorbital fine lines, and delicate corrections in thin-skin areas. [5]
• REVOLAX™ Deep: Nasolabial folds, laugh lines, marionette lines, cheek contouring, and lip augmentation. The REVOLAX™ Deep Lip Filler application is among the most widely discussed uses — practitioners should assess lip anatomy, desired shape, and tissue support needs when selecting this option. [2][5]
• REVOLAX™ Sub-Q: Chin filler, jawline definition, deep cheek volumization, and structural facial sculpting where a denser gel is needed for projection and contour correction at a greater injection depth. [2][5]

For practitioners looking to order REVOLAX™ across all three viscosity grades, Doctor Medica stocks the full range, supporting a broad treatment menu within a single Korean HA filler system.

Why Practitioners Choose REVOLAX™

Two differentiators define REVOLAX™’s position among Korean HA fillers. The first is range completeness. Fine, Deep, and Sub-Q cover the full viscosity spectrum — from glabellar lines and neck wrinkles to deep structural contouring — giving clinics a single-brand HA system that eliminates the need to switch manufacturers as treatment depth increases.

The second differentiator is regulatory and purity positioning. The rheological properties that define each REVOLAX™ grade- stiffness, cohesivity, and resistance to deformation- are central to how Korean HA fillers like REVOLAX™ are evaluated by practitioners making procurement decisions against established European alternatives. REVOLAX™’s CE marking and Korean MFDS approval give it a dual regulatory footprint that supports confident procurement in authorized markets, while its emphasis on high HA purity and minimized BDDE residual levels is relevant for practitioners comparing Korean dermal fillers on biocompatibility criteria alongside cost per syringe. [1][4][5]

Administration and Injection Technique

REVOLAX™ administration depth varies by formulation. REVOLAX™ Fine is placed in the superficial dermis to address fine lines and make delicate corrections. REVOLAX™ Deep is used in the mid-to-deep dermis or subdermal layer for nasolabial folds, lips, cheeks, and facial augmentation protocols. REVOLAX™ Sub-Q is intended for deeper subcutaneous or supraperiosteal placement where structural contouring or projection is the clinical objective. [5]

Injection technique should be adapted to the product viscosity, treatment area, and patient anatomy. The rheological characteristics of each formulation, including gel stiffness and extrusion behavior, influence needle and cannula selection, injection speed, and pressure required for consistent placement. Practitioners should inject slowly, aspirate where appropriate, and avoid intravascular product placement throughout. A thorough understanding of facial vascular anatomy is essential, as vascular compromise is a rare but serious risk associated with dermal filler procedures across all brands and formulations. [1][2]

Lidocaine variants support patient comfort and can improve treatment flow for procedures involving multiple injection passes. Following treatment, practitioners commonly advise patients to avoid excess heat, UV exposure, pressure on the treated area, alcohol, and strenuous physical activity for 24 to 48 hours, in line with standard HA filler aftercare protocols.

Regulatory Status and Safety

REVOLAX™ is CE-marked as a medical device and carries Korean MFDS regulatory authorization. CE marking applies to markets within the EU and UK, where REVOLAX™ is positioned for use by licensed medical professionals in aesthetic practice. However, product availability, approved indications, distribution rights, and the specific status of CE-marked devices in individual markets require verification — public regulatory records indicate that device registration details and authorized supply channels can vary significantly by country and should be confirmed through official sources before procurement. [4]

For practices operating in the United States, a critical distinction applies: REVOLAX™ is not currently FDA-approved or FDA-cleared for the US dermal filler market. The FDA reviews requirements to buy dermal fillers as medical devices under its Premarket Approval or Premarket Clearance pathways, based on controlled clinical data and specific labeled indications. CE marking and Korean MFDS authorization do not confer FDA approval, and US-based clinics should not treat international regulatory status as equivalent when deciding to purchase REVOLAX™ wholesale or source it internationally. [3]

REVOLAX™ vs Competing Korean HA Fillers

REVOLAX™ vs DERMALAX™

REVOLAX™ and DERMALAX™ are both Korean HA filler ranges used for aesthetic correction and contouring, with product lines organized around viscosity grades and treatment depth. Practitioners comparing the two typically focus on HA concentration, lidocaine options, cross-linking technology, and injection feel by treatment area. Clinics that stock DERMALAX™ alongside REVOLAX™ cover a broader Korean filler selection — buy DERMALAX™ through Doctor Medica to assess both ranges.

REVOLAX™ vs NEURAMIS®

REVOLAX™ and NEURAMIS® are Korean HA filler peers with overlapping indications for wrinkle correction, facial contouring, and lip augmentation. REVOLAX™’s Fine, Deep, and Sub-Q structure provides a straightforward viscosity ladder, while NEURAMIS® offers its own line of lidocaine and non-lidocaine variants. Practitioners comparing gel firmness, duration, and product breadth may find value in stocking both; buy NEURAMIS® to evaluate where it fits alongside a REVOLAX™-based protocol.

REVOLAX™ vs BELLAST®

Both REVOLAX™ and BELLAST® are Korean HA fillers used in aesthetic medicine, but they differ in technology positioning, product range architecture, and market presence. REVOLAX™ is often chosen for its clearly segmented three-grade structure, while BELLAST® may be evaluated for its own HA formulation, pricing, and treatment-area coverage. For clinics building a Korean filler inventory, buy BELLAST® to compare product behavior and depth of range side by side with REVOLAX™.

REVOLAX™ vs REVOFIL

REVOLAX™ and REVOFIL both occupy the Korean filler market but differ in cross-linking approach and technology claims. REVOLAX™ focuses on monophasic cross-linked HA across Fine, Deep, and Sub-Q, while REVOFIL is often discussed in relation to peptide-linked HA technology and its implications for tissue integration. Practitioners for whom cross-linking mechanism and purity claims are the primary selection criteria should buy REVOFIL to compare directly with REVOLAX™ formulations.

REVOLAX™ vs INTRALINE®

REVOLAX™ and INTRALINE® are both HA filler brands used for wrinkle correction, lip enhancement, and facial contouring, but they differ in product segmentation and treatment-area focus. REVOLAX™’s three-grade system provides a structured viscosity range, while INTRALINE® has its own product architecture and positioning. Clinics that buy INTRALINE® alongside REVOLAX™ gain access to an additional HA option that may suit specific patient profiles or treatment depths outside REVOLAX™’s primary range.

REVOLAX™ vs PERFECTHA®

REVOLAX™ and PERFECTHA® represent Korean and European HA filler positioning respectively, making this comparison relevant for clinics evaluating geographic market pedigree alongside technology. PERFECTHA® is associated with European filler manufacturing and cross-linking standards, while REVOLAX™ competes on Korean purity credentials and competitive price per syringe. Practitioners weighing these factors can buy PERFECTHA® to assess European HA filler alternatives against REVOLAX™’s Korean monophasic formulation.

REVOLAX™ Safety Profile — Adverse Events and Contraindications

Common adverse events associated with REVOLAX™ are generally consistent with HA dermal filler procedures and may include injection-site redness, swelling, bruising, tenderness, itching, firmness, or transient discomfort. These reactions are typically short-lived, though duration varies by treatment area, injection depth, patient sensitivity, and technique. Clinical evidence on HA fillers confirms that adverse event profiles at equivalent injection depths are broadly comparable across formulations, with most reactions resolving without intervention. [2]

Rare but serious complications may include nodule formation, infection, inflammatory reactions, vascular occlusion, tissue ischemia, and — in the periocular region — visual complications if filler enters the vasculature. Prior to treatment, practitioners should evaluate allergy history, active skin infection, prior filler complications, pregnancy or lactation status, and lidocaine sensitivity. Lidocaine-containing REVOLAX™ variants should not be used in patients with known lidocaine allergy. As with all HA fillers, safe outcomes depend on professional training, anatomical knowledge, sterile technique, and sourcing through verified, authenticated supply channels. [2][3]

Doctor Medica has supplied Korean and international dermal fillers to licensed medical professionals since 2006, offering guaranteed authenticity, verifiable LOT numbers, and competitive wholesale pricing. Practitioners looking to buy REVOLAX™ online or browse the full range can explore the Doctor Medica catalog — contact representatives for availability, documentation, and support.

FAQs

What is REVOLAX™?

REVOLAX™ is a highly purified, CE-marked Korean HA dermal filler available in three viscosity grades — Fine, Deep, and Sub-Q — each with and without lidocaine. The range is used for wrinkle correction, lip augmentation, facial contouring, and deep volumization across a broad spectrum of treatment areas. [5]

What is REVOLAX™ made of?

REVOLAX™ is made of biodegradable, cross-linked hyaluronic acid of non-animal origin, formulated as a monophasic gel. The monophasic structure is designed to support smooth injection, a consistent texture, and predictable tissue integration, with gel properties — including stiffness and cohesivity — determined by the degree of cross-linking and HA concentration. [1][5]

How long does REVOLAX™ last?

Duration varies by product, treatment area, patient metabolism, and injection technique. REVOLAX™ Fine is typically described as lasting approximately 6 to 9 months. REVOLAX™ Deep and Sub-Q are used for deeper correction and may last approximately 12 to 18 months in selected patients. Individual results may vary. [2][5]

What is the difference between REVOLAX™ Fine, Deep, and Sub-Q?

REVOLAX™ Fine is a lower-viscosity option for superficial correction — fine lines, glabellar lines, and neck wrinkles. REVOLAX™ Deep is a medium-viscosity filler for nasolabial folds, lips, cheeks, and marionette lines. REVOLAX™ Sub-Q is the highest-viscosity option for deep volumization, chin augmentation, jawline contouring, and structural facial support. [5]

Is REVOLAX™ FDA-approved?

No. REVOLAX™ is not currently FDA-approved or FDA-cleared for the US market. It holds CE marking for EU/UK markets and Korean MFDS authorization, but neither confers FDA approval. US-based practitioners should confirm the regulatory status of any filler before procurement. [3]

Is REVOLAX™ safe?

REVOLAX™ carries CE marking and Korean MFDS authorization, with an adverse event profile generally consistent with HA dermal fillers. Common risks include transient injection-site reactions such as swelling, bruising, and tenderness, while rare vascular events are technique-dependent. Safety depends on authentic sourcing, correct patient selection, proper injection technique, and practitioner training. [2][3]

REVOLAX™ vs JUVÉDERM® — what are the key differences?

Both are cross-linked HA fillers, but they differ in their manufacturers, regulatory footprints, and technologies. REVOLAX™ is a Korean-manufactured range using monophasic cross-linked HA; JUVÉDERM® is an Allergan/AbbVie product portfolio using proprietary VYCROSS and Hylacross technologies. Clinicians typically compare viscosity grades, duration, reversibility, approved market status, and cost per syringe. [1]

RESTYLANE® vs REVOLAX™ — how do they compare?

Both are HA filler brands with multi-product ranges and varying gel technologies. Restylane® is associated with NASHA and OBT/XpresHAn technologies depending on the product, while REVOLAX™ uses Korean monophasic cross-linked HA. Comparisons between Restylane vs REVOLAX™ should be made product-by-product based on viscosity, treatment area, duration, and regulatory status. [1]

Where can practitioners buy REVOLAX™ wholesale?

Practitioners can buy REVOLAX™ wholesale through Doctor Medica, which has supplied Korean and international dermal fillers to licensed professionals at competitive prices since 2006. Representatives can assist with availability, documentation, and LOT number verification.

Citations

1. Wongprasert P, Dreiss CA, Murray G. Evaluating hyaluronic acid dermal fillers: A critique of current characterization methods. Dermatologic Therapy. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9285697/
2. Alessandrini A, Fino P, Giordan N, Amorosi V, Scuderi N. Evaluation of a new hyaluronic acid dermal filler for volume restoration. Journal of Cosmetic and Laser Therapy. 2015. https://pubmed.ncbi.nlm.nih.gov/25968167/
3. S. Food and Drug Administration. FDA-Approved Dermal Fillers. Updated 2020. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers
4. Medicines & Healthcare products Regulatory Agency. Freedom of Information request on REVOLAX™ and CE marking (FOI 21/1044). GOV.UK. 2022. https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-4-october-2021/freedom-of-information-request-on-revolax-and-ce-marking-foi-211044
5. Across Co., Ltd. REVOLAX™™ Firm & Lasting Hyaluronic Acid Dermal Filler Manufacturer Brochure. 2022. https://static1.squarespace.com/static/6225addb65eac13c52ba4ce1/t/62c691715a2870480b58df2f/1657180531989/REVOLAX™+Brochure.pdf

For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.